Matthias Zeiler

Dr. Matthias Zeiler

C. e G. Mazzoni Hospital, Ancona, Marche, Italy
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2000 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
VNVolker Nickeleit
Volker Nickeleit
HHHans H. Hirsch
Hans H. Hirsch
MZMatthias Zeiler
Matthias Zeiler
FGFred Gudat
Fred Gudat
OPOlivier Prince
Olivier Prince
MMMichael J. Mihatsch
Michael J. Mihatsch
We review BK-virus nephropathy (BKN) as a new complication that increasingly affects renal allografts and causes dysfunction. Since starting in 1996, we have seen 11 cases. Currently, the prevalence of BKN is 3% in our graft biopsies. The diagnosis can only be made histologically. The virus affects tubular epithelial cells that show characteristic intranuclear inclusion bodies. The major reason for impaired graft function and a possible way for viral particles to gain access to the blood via peritubular capillaries is necrosis of infected epithelial cells. BK-virus DNA in the plasma, which can be detected by PCR, is closely associated with nephropathy. BK-virus does not stimulate tubular MHC-class II expression as judged by immunofluorescence double labelling. The inflammatory response is inconsistent and the frequency of rejection episodes is not increased during disease. Clinical manifestation of viral nephropathy evolves in several stages. (i) Initial, asymptomatic and reversible activation of the virus, judged by the presence of inclusion bearing cells in the urine. (ii) High dose immunosuppressive drug regimens, often including tacrolimus. (iii) Tubular injury and viraemia as additional promoting conditions. BKN nephropathy was associated with graft loss in 45% of our patients. The remaining patients with persistent viral nephropathy showed renal dysfunction (serum creatinine levels on average 150% above baseline readings). Currently, no established antiviral therapy is available. We discuss attempts to lower immunosuppression as a means to control viral replication. We propose a diagnostic algorithm for screening and monitoring the disease.

18 January 2006 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
SSStefano Santarelli
Stefano Santarelli
MZMatthias Zeiler
Matthias Zeiler
RMRita Marinelli
Rita Marinelli
TMTania Monteburini
Tania Monteburini
AFAntonio Federico
Antonio Federico
ECEmilio Ceraudo
Emilio Ceraudo
Background. Malfunction of the peritoneal catheter is a frequent complication in peritoneal dialysis (PD). Videolaparoscopy is a minimal invasive technique that allows rescue therapy of malfunctioning catheters and consecutive immediate resumption of PD. Furthermore, Tenckhoff catheters can be safely positioned in patients with previous abdominal surgery. We analysed the clinical diagnosis, videolaparoscopic treatment and the outcome of PD patients on whom videolaparoscopic interventions had been performed at our centre. Methods. Thirty-two cases of videolaparoscopic interventions were performed for salvage of malfunctioning peritoneal catheters, implantation and abdominal surgical interventions in 25 PD patients. The videolaparoscope was inserted through a mini-laparotomy site of 15 mm diameter which was closed with purse-string sutures at the end of the intervention. Results. Videolaparoscopy was used in 21 cases of catheter malfunction mostly due to omental wrapping (12 cases) and dislocation (five cases). In eight patients with previous surgical abdominal interventions, laparoscopic placement of the PD catheter was performed. In two cases the gall bladder was removed. One case of intestinal occlusion was evaluated laparoscopically in an attempt to minimize invasive surgery. Leakage of the peritoneal fluid presented the only complication caused by insufficient closure of one mini-laparotomy site. Minimal follow-up time of rescued catheters was 5 months. Videolaparoscopy prolonged PD catheter function by a median of 163 days (range 5–1469 days). Conclusions. Videolaparoscopy prolongs peritoneal catheter survival by treating directly the causes of malfunction. In patients with preceding abdominal interventions, the PD catheter can be placed safely even in cases necessitating surgical preparation like adhesiolysis.

1 January 2002
Verified
Journal Article
Closed access
VNVolker Nickeleit
Volker Nickeleit
MZMatthias Zeiler
Matthias Zeiler
FGFred Gudat
Fred Gudat
GTGilbert Thiel
Gilbert Thiel
MMM J Mihatsch
M J Mihatsch

8 June 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
AGAntonio Granata
Antonio Granata
ICIrene Campo
Irene Campo
PLPaolo Lentini
Paolo Lentini
FPFrancesco Pesce
Francesco Pesce
LGLoreto Gesualdo
Loreto Gesualdo
MBMichele Bertolotto
Michele Bertolotto
Gray scale ultrasound has an important diagnostic role in native kidney disease. Low cost, absence of ionizing radiation and nephrotoxicity, short performance time, and repeatability even at the bedside, are the major advantages of this technique. The introduction of contrast enhancement ultrasound (CEUS) in daily clinical practice has significantly reduced the use of contrast enhancement computed tomography (CECT) and contrast enhancement magnetic resonance (CEMR), especially in patients with renal disease. Although there are many situations in which CECT and CEMRI are primarily indicated, their use may be limited by the administration of the contrast medium, which may involve a risk of renal function impairment, especially in the elderly, and in patients with acute kidney injury (AKI) and moderate to severe chronic kidney disease (CKD). In these cases, CEUS can be a valid diagnostic choice. To date, numerous publications have highlighted the role of CEUS in the study of parenchymal micro-vascularization and renal pathology by full integration with second level imaging methods (CECT and CEMRI) both in patients with normal renal function and with diseased kidneys. The aim of this review is to offer an updated overview of the limitations and potential applications of CEUS in native kidney disease.

29 March 2021 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
AGAntonio Granata
Antonio Granata
ERElnaz Rahbari
Elnaz Rahbari
PNPierpaolo Di Nicolò
Pierpaolo Di Nicolò
Yuri BattagliaYuri Battaglia
Yuri Battaglia
ICIrene Campo
Irene Campo
MZMatthias Zeiler
Matthias Zeiler

1 July 1998 in Kidney and Blood Pressure Research
Verified
Journal Article
Closed access
PDF file
VNV. Nickeleit
V. Nickeleit
MZMatthias Zeiler
Matthias Zeiler
FGF. Gudat
F. Gudat
GTG. Thiel
G. Thiel
MMM.J. Mihatsch
M.J. Mihatsch